Cargando…

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO

BACKGROUND: Patients with recurrent/metastatic endometrial cancer that progresses after chemotherapy have limited treatment options and poor outcomes. Preclinical data suggest the oral mammalian target of rapamycin inhibitor everolimus may provide clinical benefit in these patients. METHODS: In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ray-Coquard, I, Favier, L, Weber, B, Roemer-Becuwe, C, Bougnoux, P, Fabbro, M, Floquet, A, Joly, F, Plantade, A, Paraiso, D, Pujade-Lauraine, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658508/ https://www.ncbi.nlm.nih.gov/pubmed/23612453 http://dx.doi.org/10.1038/bjc.2013.183

Ejemplares similares

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group
por: Heudel, P-E, et al.
Publicado: (2017)

Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO group
por: Ray-Coquard, I, et al.
Publicado: (2007)

Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group
por: Ray-Coquard, I, et al.
Publicado: (2009)

Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study
por: Falandry, Claire, et al.
Publicado: (2015)

HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients
por: Tuefferd, Marianne, et al.
Publicado: (2007)

Predicting tumor response and outcome of second-look surgery with (18)F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer
por: Aide, Nicolas, et al.
Publicado: (2020)

Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)
por: Elie, C, et al.
Publicado: (2004)

Histerectomia en gineco-obstetricia
por: Rodríguez Velázquez, Rodolfo
Publicado: (1999)

Gineco-obstetricia : de la niñez a la senectud
por: Mondragón Castro, Héctor
Publicado: (2006)

Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group
por: Mourksi, Nour‐El‐Houda, et al.
Publicado: (2022)

Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network
por: Nigon, Elsa, et al.
Publicado: (2023)

Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2022)

Hospital universitario de gineco-obstetricia /
por: Cadena Rojas, María Esther
Publicado: (1993)

Monografía de gineco-obstetricia prehispanica /
por: Pérez de Salazar, J. L.

Everolimus is Safe as a Second-/Third-Line Therapy in Pediatric Autoimmune Hepatitis
por: Jannone, Giulia, et al.
Publicado: (2022)

Problemas gineco-obstétricos de la adolescencia. /
por: Vázquez García, Luz Arcelia
Publicado: (1996)

Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
por: Pujade-Lauraine, Eric
Publicado: (2013)

Métodos auxiliares en el diagnóstico gineco-obstétrico /
por: Rodríguez Hernández, Rosa Amada
Publicado: (1995)

“Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors”
por: Gernier, François, et al.
Publicado: (2021)

Unidad medico integral de gineco.obstetricia Xalapa, Ver. /
por: Arias Pozos, Paloma Iveth
Publicado: (2006)

Temas selectos de gineco-obstetricia: libro homenaje ofrecido al prof. Dr. Alfonso Alvarez Bravo /

Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients
por: Berton, Dominique, et al.
Publicado: (2021)

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
por: Ledermann, Jonathan A., et al.
Publicado: (2019)

Dehincencia de herida quirúrgica en la paciente gineco-obstétrica
por: Galindo Ortega, Lilia
Publicado: (1997)

Manual de procedimientos para el area de gineco-obstetricia
por: Villa Lara, María Guadalupe
Publicado: (1994)

Estudios clínicos y paraclínicos auxiliares en el diagnostico gineco-obstetrico.
por: Contreras Rodriguez, Victor Manuel
Publicado: (1994)

Pathological findings after third- and second-generation everolimus-eluting stent implantations in coronary arteries from autopsy cases and an atherosclerotic porcine model
por: Migita, Suguru, et al.
Publicado: (2021)

Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors
por: Lainé, Alexandra, et al.
Publicado: (2023)

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium
por: Ray-Coquard, Isabelle, et al.
Publicado: (2019)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
por: Whitbeck, Matthew G., et al.
Publicado: (2013)

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?
por: Cappelletti, Maria Rosa, et al.
Publicado: (2015)

Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma
por: Christinat, Yann, et al.
Publicado: (2023)

Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2020)

Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
por: Fujiwara, Keiichi, et al.
Publicado: (2021)

"Procesamiento del instrumental quirúrgico para cesárea del Hospital Escuela de Gineco-Obstetricia de la Universidad Veracruzana"/
por: Landa Martínez, Ana María
Publicado: (2002)

Detección y control de la desnutrición en preescolares internados en el hospital Gineco-Pediatría no. 31, Mexicali
por: Ramos Espindola, Angel
Publicado: (1991)

High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β
por: Ullah, Matti, et al.
Publicado: (2019)

Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice
por: Dubois, Martine, et al.
Publicado: (2014)

CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data
por: Karamouza, Eleni, et al.
Publicado: (2023)

Second and Third Virial Coefficients for Hydrogen
por: Goodwin, R. D., et al.
Publicado: (1964)

Cannot write session to /tmp/vufind_sessions/sess_0fuirmbibq456vugsq7jnv4tvh